-
Multicenter Study Comparative Study
Use of PROMIS-29® in US Veterans: Diagnostic Concordance and Domain Comparisons with the General Population.
- Sherri L LaVela, Bella Etingen, Scott Miskevics, and David Cella.
- Department of Veterans Affairs, Center of Innovation for Complex Chronic Healthcare, Health Services Research & Development, Edward Hines Jr. VA Hospital, Hines, IL, USA. sherri.lavela@va.gov.
- J Gen Intern Med. 2019 Aug 1; 34 (8): 1452-1458.
BackgroundPROMIS® items have not been widely or systematically used within the Veterans Health Administration (VA).ObjectiveTo examine the concordance of PROMIS-29® scores and medical record diagnosis in US Veterans and to compare Veteran scores relative to US population norms.Design/ParticipantsCross-sectional multi-site survey of Veterans (n = 3221) provided sociodemographic and PROMIS-29® domain data. Electronic medical records provided health condition (depression, anxiety, sleep disorders, pain disorders) diagnosis data.Main MeasuresFor each domain, we calculated PROMIS® standardized T scores and used t tests to compare PROMIS® scores for Veterans diagnosed with each targeted health condition vs. those without that documented clinical diagnosis and compare mean Veterans' PROMIS-29® with US adult population norms.Key ResultsVeterans with (vs. without) a depression diagnosis reported significantly higher PROMIS® depression scores (60.3 vs. 49.6, p < .0001); those with an anxiety diagnosis (vs. without) reported higher average PROMIS® anxiety scores (62.7 vs. 50.9, p < .0001). Veterans with (vs. without) a pain disorder reported higher pain interference (65.3 vs. 57.7, p < .0001) and pain intensity (6.4 vs. 4.4, p < .0001). Veterans with (vs. without) a sleep disorder reported higher sleep disturbance (55.8 vs. 51.2, p < .0001) and fatigue (57.5 vs. 51.8, p < .0001) PROMIS® scores. Compared with the general population norms, Veterans scored worse across all PROMIS-29® domains.ConclusionsWe found that PROMIS-29® domains are selectively sensitive to expected differences between clinically-defined groups, suggesting their appropriateness as indicators of condition symptomology among Veterans. Notably, Veterans scored worse across all PROMIS-29(R) domains compared with population norms. Taken collectively, our findings suggest that PROMIS-29® may be a useful tool for VA providers to assess patient's physical and mental health, and because PROMIS® items are normed to the general population, this offers a way to compare the health of Veterans with the adult population at large and identify disparate areas for intervention.
Notes
Knowledge, pearl, summary or comment to share?